inTEST Corporation (INTT) - 10-K Filing Summary
Business Context and Reporting Period
Company: inTEST Corporation
Filing Type: Form 10-K (Annual Report)
Period Ended: December 31, 2024
Business Overview: inTEST is a global supplier of test and process technology solutions for semiconductor, industrial, automotive, life sciences, defense/aerospace, and security markets. The company operates through three segments: Electronic Test, Environmental Technologies, and Process Technologies.
Key Strategic Event: On March 12, 2024, the company acquired Alfamation S.p.A. for approximately $21.9 million to expand its presence in the automotive and life sciences markets and its geographic footprint in Europe.
Key Financial Metrics
| Metric (in thousands) | 2024 | 2023 |
|---|---|---|
| Revenue | $130,690 | $123,302 |
| Gross Profit | $55,424 | $56,978 |
| Gross Margin | 42.4% | 46.2% |
| Operating Income | $3,394 | $10,439 |
| Net Earnings | $2,891 | $9,342 |
| Diluted EPS | $0.24 | $0.79 |
| Operating Cash Flow | $3,821 | $16,203 |
| Cash and Equivalents (Year End) | $19,830 | $45,260 |
| Total Debt (Current + Long-term) | $15,032 | $12,042 |
| Backlog (Unfilled Orders) | $39,500 | $40,100 |
Material Changes vs. Prior Period
- Revenue Growth: Consolidated revenue increased 6.0% to $130.7 million, driven primarily by the Alfamation acquisition ($25.0 million contribution) and growth in the Automotive/EV (+232.2%) and Defense/Aerospace (+22.2%) markets.
- Semi Market Decline: Revenue from the semiconductor market, historically the largest segment, decreased 25.9% to $48.7 million due to cyclical downturns in both front-end (SiC crystal growth) and back-end testing demand.
- Profitability Compression: Net earnings declined 69% to $2.9 million. Gross margin contracted from 46% to 42%, impacted by a $1.6 million inventory step-up charge related to the Alfamation acquisition, higher fixed costs, and increased direct labor.
- Expense Increases: General and Administrative expenses rose 22% to $26.1 million, largely due to the inclusion of Alfamation operations and amortization of acquired intangibles.
- Liquidity: Cash and cash equivalents decreased by $25.4 million, primarily due to the cash portion of the Alfamation acquisition ($19.7 million) and debt repayments ($7.8 million).
Guidance, Outlook, and Risks
- Strategic Outlook: Management revised its 5-Point Strategy timeline, acknowledging that the goal to reach $200M–$250M in annual revenue will extend beyond the original 2025 target due to simultaneous cyclical downturns in semi, automotive, and industrial markets in late 2023 and 2024.
- Market Trends: While the semi market remains soft, management noted a modest improvement in back-end semi demand in Q4 2024. The company continues to pursue diversification into non-semiconductor markets to reduce cyclicality.
- Restructuring: In February 2025, the company announced the consolidation of Videology operations from the Netherlands to Massachusetts, expecting one-time cash charges of $0.55M–$0.65M for severance and facility costs.
- Supply Chain Risks:
- Belarus: Acculogic relies on a sole-source supplier in Belarus for certain parts. Due to sanctions, the company has not received materials since August 2024 and is qualifying an alternate supplier, with a temporary license application pending with OFAC.
- Israel: Ambrell relies on a sole-source capacitor supplier in Israel. While the supplier reports redundancy, the ongoing conflict poses a risk to supply continuity.
- Internal Controls: The company remediated material weaknesses in internal controls identified in 2023 and Q3 2024 related to revenue recognition and procurement accounting. The 2024 audit received an unqualified opinion on internal controls.
Investor Verification Checklist
- Acquisition Integration: Verify the realization of synergies and revenue growth from the Alfamation acquisition against the $25M contribution in 2024.
- Semi Market Recovery: Monitor order activity and backlog trends in the semiconductor front-end market, which remains significantly depressed compared to 2023 levels.
- Supply Chain Mitigation: Confirm the successful qualification of the alternate supplier for Acculogic parts previously sourced from Belarus and the status of the OFAC license application.
- Margin Trajectory: Assess whether gross margins can recover to historical levels (46%+) once the one-time inventory step-up charges from the Alfamation acquisition are fully absorbed.
- Debt Covenants: Review compliance with the M&T Bank credit facility covenants, specifically the fixed charge coverage ratio, given the recent waiver received in Q2 2024.